ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.

Saved in:
Bibliographic Details
Title: ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.
Authors: Morazzo S; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Fernandes S; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Fortea M; European Molecular Biology Laboratory, Barcelona, Spain., Skálová H; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Pereira-Sousa D; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Cassani M; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Vrzalová K; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czechia., Kafka F; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Vrbský J; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Soulez M; Institute for Research in Immunology and Cancer, Montreal, QC, Canada., Meloche S; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada., Morten-Seternes O; Department of Pharmacy, UIT The Arctic University of Norway, Tromso, Norway., Bosáková V; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Shin J; AtoGen Co., Ltd., Daejeon, Republic of Korea., Frič J; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Institute of Hematology and Blood Transfusion, Prague, Czechia.; International Clinical Research Center (ICRC), Faculty of Medicine, Masaryk University, Brno, Czechia., Haase K; European Molecular Biology Laboratory, Barcelona, Spain., Forte G; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; School of Cardiovascular and Metabolic Medicine and Sciences, King's College, London, United Kingdom.
Source: Frontiers in oncology [Front Oncol] 2025 Aug 27; Vol. 15, pp. 1563969. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40936697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Morazzo+S%22">Morazzo S</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Fernandes+S%22">Fernandes S</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Fortea+M%22">Fortea M</searchLink>; European Molecular Biology Laboratory, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Skálová+H%22">Skálová H</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Pereira-Sousa+D%22">Pereira-Sousa D</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Cassani+M%22">Cassani M</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Vrzalová+K%22">Vrzalová K</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Kafka+F%22">Kafka F</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Vrbský+J%22">Vrbský J</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Soulez+M%22">Soulez M</searchLink>; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Meloche+S%22">Meloche S</searchLink>; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Morten-Seternes+O%22">Morten-Seternes O</searchLink>; Department of Pharmacy, UIT The Arctic University of Norway, Tromso, Norway.<br /><searchLink fieldCode="AU" term="%22Bosáková+V%22">Bosáková V</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; AtoGen Co., Ltd., Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Frič+J%22">Frič J</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Institute of Hematology and Blood Transfusion, Prague, Czechia.; International Clinical Research Center (ICRC), Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Haase+K%22">Haase K</searchLink>; European Molecular Biology Laboratory, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Forte+G%22">Forte G</searchLink>; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; School of Cardiovascular and Metabolic Medicine and Sciences, King's College, London, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Aug 27; Vol. 15, pp. 1563969. <i>Date of Electronic Publication: </i>2025 Aug 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40936697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1563969
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1563969
    Titles:
      – TitleFull: ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Morazzo S
      – PersonEntity:
          Name:
            NameFull: Fernandes S
      – PersonEntity:
          Name:
            NameFull: Fortea M
      – PersonEntity:
          Name:
            NameFull: Skálová H
      – PersonEntity:
          Name:
            NameFull: Pereira-Sousa D
      – PersonEntity:
          Name:
            NameFull: Cassani M
      – PersonEntity:
          Name:
            NameFull: Vrzalová K
      – PersonEntity:
          Name:
            NameFull: Kafka F
      – PersonEntity:
          Name:
            NameFull: Vrbský J
      – PersonEntity:
          Name:
            NameFull: Soulez M
      – PersonEntity:
          Name:
            NameFull: Meloche S
      – PersonEntity:
          Name:
            NameFull: Morten-Seternes O
      – PersonEntity:
          Name:
            NameFull: Bosáková V
      – PersonEntity:
          Name:
            NameFull: Shin J
      – PersonEntity:
          Name:
            NameFull: Frič J
      – PersonEntity:
          Name:
            NameFull: Haase K
      – PersonEntity:
          Name:
            NameFull: Forte G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 08
              Text: 2025 Aug 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1